These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 26546407

  • 1. New Insights into Eosinophilic Otitis Media.
    Kanazawa H, Yoshida N, Iino Y.
    Curr Allergy Asthma Rep; 2015 Dec; 15(12):76. PubMed ID: 26546407
    [Abstract] [Full Text] [Related]

  • 2. Risk factors associated with severity of eosinophilic otitis media.
    Kanazawa H, Yoshida N, Yamamoto H, Hara M, Hasegawa M, Matsuzawa S, Shinnabe A, Iino Y.
    Auris Nasus Larynx; 2014 Dec; 41(6):513-7. PubMed ID: 25199747
    [Abstract] [Full Text] [Related]

  • 3. Antigen-specific IgE in middle ear effusion of patients with eosinophilic otitis media.
    Kanazawa H, Yoshida N, Shinnabe A, Iino Y.
    Ann Allergy Asthma Immunol; 2014 Jul; 113(1):88-92. PubMed ID: 24863399
    [Abstract] [Full Text] [Related]

  • 4. Role of IgE in eosinophilic otitis media.
    Iino Y.
    Allergol Int; 2010 Sep; 59(3):233-238. PubMed ID: 20657163
    [Abstract] [Full Text] [Related]

  • 5. Eosinophilic otitis media: a new middle ear disease entity.
    Iino Y.
    Curr Allergy Asthma Rep; 2008 Nov; 8(6):525-30. PubMed ID: 18940145
    [Abstract] [Full Text] [Related]

  • 6. Eosinophil chemoattractants in the middle ear of patients with eosinophilic otitis media.
    Iino Y, Kakizaki K, Katano H, Saigusa H, Kanegasaki S.
    Clin Exp Allergy; 2005 Oct; 35(10):1370-6. PubMed ID: 16238798
    [Abstract] [Full Text] [Related]

  • 7. Clinical efficacy of anti-IL-5 monoclonal antibody mepolizumab in the treatment of eosinophilic otitis media.
    Iino Y, Takahashi E, Ida S, Kikuchi S.
    Auris Nasus Larynx; 2019 Apr; 46(2):196-203. PubMed ID: 30122651
    [Abstract] [Full Text] [Related]

  • 8. Effectiveness of instillation of triamcinolone acetonide into the middle ear for eosinophilic otitis media associated with bronchial asthma.
    Iino Y, Nagamine H, Kakizaki K, Komiya T, Katano H, Saruya S, Kodera K.
    Ann Allergy Asthma Immunol; 2006 Dec; 97(6):761-6. PubMed ID: 17201235
    [Abstract] [Full Text] [Related]

  • 9. Eosinophilic inflammation in the middle ear induces deterioration of bone-conduction hearing level in patients with eosinophilic otitis media.
    Iino Y, Usubuchi H, Kodama K, Kanazawa H, Takizawa K, Kanazawa T, Ohta Y.
    Otol Neurotol; 2010 Jan; 31(1):100-4. PubMed ID: 19816234
    [Abstract] [Full Text] [Related]

  • 10. Eosinophilic otitis media; state-of-the-art diagnosis and treatment.
    Iino Y.
    Auris Nasus Larynx; 2023 Aug; 50(4):479-489. PubMed ID: 36528403
    [Abstract] [Full Text] [Related]

  • 11. Eosinophilic otitis media and comorbid asthma.
    Seo Y, Nonaka M, Pawankar R.
    Curr Opin Allergy Clin Immunol; 2020 Feb; 20(1):9-13. PubMed ID: 31524656
    [Abstract] [Full Text] [Related]

  • 12. Eosinophil-derived neurotoxin, elastase, and cytokine profile in effusion from eosinophilic otitis media.
    Uchimizu H, Matsuwaki Y, Kato M, Otori N, Kojima H.
    Allergol Int; 2015 Sep; 64 Suppl():S18-23. PubMed ID: 26344075
    [Abstract] [Full Text] [Related]

  • 13. Effect of omalizumab on biomarkers in middle ear effusion in patients with eosinophilic otitis media.
    Iino Y, Hara M, Hasegawa M, Matsuzawa S, Shinnabe A, Kanazawa H, Yoshida N.
    Acta Otolaryngol; 2014 Apr; 134(4):366-72. PubMed ID: 24628335
    [Abstract] [Full Text] [Related]

  • 14. Differentiation Between Eosinophilic Otitis Media and Otitis Media Associated With Eosinophilic Granulomatosis With Polyangiitis.
    Fukuda A, Morita S, Nakamaru Y, Hoshino K, Fujiwara K, Homma A.
    Otol Neurotol; 2019 Sep; 40(8):e796-e802. PubMed ID: 31290803
    [Abstract] [Full Text] [Related]

  • 15. Dupilumab therapy for patients with refractory eosinophilic otitis media associated with bronchial asthma.
    Iino Y, Sekine Y, Yoshida S, Kikuchi S.
    Auris Nasus Larynx; 2021 Jun; 48(3):353-360. PubMed ID: 32943257
    [Abstract] [Full Text] [Related]

  • 16. [Eosinophilic otitis media and eosinophilic chronic -hinosinusitis].
    Matsubara A, Takahata J, Kudo N, Noro M, Miura T.
    Nihon Rinsho; 2016 Oct; 74(10):1717-1720. PubMed ID: 30551286
    [Abstract] [Full Text] [Related]

  • 17. Successful treatment of eosinophilic otitis media associated with severe bronchial asthma with an anti-IL-5 monoclonal antibody, mepolizumab.
    Suzaki I, Kimura Y, Tanaka A, Hirano K, Ishibashi A, Mizuyoshi T, Ando I, Kitajima T, Watanabe S, Hinohira Y, Kobayashi H.
    Auris Nasus Larynx; 2019 Feb; 46(1):141-146. PubMed ID: 29909018
    [Abstract] [Full Text] [Related]

  • 18. Intractable otitis media - Pathogenesis and treatment of Eosinophilic otitis media (EOM) and otitis media with Antineutrophil cytoplasmic antibody (ANCA) -associated vasculitis (OMAAV).
    Yoshida N.
    Auris Nasus Larynx; 2023 Apr; 50(2):171-179. PubMed ID: 35934599
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.